Scorpius Holdings, Inc. (SCPX)

USD 0.29

(-0.87%)

Market Cap (In USD)

1.27 Million

Revenue (In USD)

6.99 Million

Net Income (In USD)

-45.21 Million

Avg. Volume

142.34 Thousand

Currency
USD
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
0.02-8.11
PE
-
EPS
-
Beta Value
-0.326
ISIN
US42237K4094
CUSIP
-
CIK
1476963
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Biotechnology
CEO
Mr. Jeffrey Alan Wolf J.D.
Employee Count
-
Website
https://www.scorpiusbiologics.com
Ipo Date
2013-07-24
Details
Scorpius Holdings Inc., through its subsidiary Scorpius BioManufacturing, operates as an integrated contract development and manufacturing organization. The company provides analytical testing, downstream process development, formulation optimization and development, and clinical biomanufacturing services to pharmaceutical and biotech companies. It is also involved in the provision of pre-clinical and product development; chemistry, manufacturing, and control analytical support; and bioassays. The company was formerly known as NightHawk Biosciences, Inc. and changed its name to Scorpius Holdings, Inc. in February 2024. Scorpius Holdings, Inc. was incorporated in 2008 and is based in Morrisville, North Carolina.